"I would like to mention that we do have plans to reduce the pledges significantly, by at least 50 per cent in the next six months. The 5 per cent increase happened because we had an instrument with KKR and in January we had to unwind that instrument. We have planned two liquidity events. We believe that they will happen in the next six months," she told analysts today, adding that it could even happen in the next quarter.
The US-based KKR had infused Rs 550 crore in AHEL's holding company PCR Investments in October 2013, which was expected to be used to repay promoters' debt and build more hospitals. Following the unwinding of the instrument, Sanjay Nayar, member and CEO of KKR India, who has been an independent director of the company since 2014, has resigned from the board with effect from February 9, 2019. KKR has, of late, increased its stake in Max Hospitals.